Paras Healthcare IPO Details
IPO Overview
| Lot Size | 1 shares |
|---|---|
| Total Subscription | 0 times |
| Status | Upcoming |
IPO Tentative Timetable
| IPO Open Date | Oct 21, 2026 |
|---|---|
| IPO Close Date | Oct 23, 2026 |
| Allotment Date | Oct 26, 2026 |
| Refund Initiation | Oct 27, 2026 |
| Listing Date | Oct 28, 2026 |
IPO Detail
| Face Value | ₹1 per share |
|---|---|
| Sale Type | Fresh capital cum OFS |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE, NSE |
| Total Issue Size | [.] shares (agg. up to ₹1,450 Cr) |
| Fresh Issue | [.] shares (agg. up to ₹500 Cr) |
| Offer for Sale | [.] shares of ₹1 (agg. up to ₹950 Cr) |
| Share Holding Pre Issue | 10,09,86,187 shares |
Company Financials (In Crore)
| Period Ended | Assets | Total Income | Profit After Tax | E B I T D A | N E T Worth | Reserves And Surplus | Total Borrowing |
|---|---|---|---|---|---|---|---|
| 30 Jun 2026 | 2,202.88 | 478.75 | 49.68 | 113.48 | 444.96 | 434.86 | 1,429.49 |
| 31 Mar 2026 | 2,071.14 | 1,628.78 | 43.83 | 335.58 | 394.94 | 384.84 | 1,393.86 |
| 31 Mar 2025 | 1,810.45 | 1,314.21 | -57.98 | 156.46 | 280.49 | 270.73 | 1,232.12 |
| 31 Mar 2024 | 1,477.66 | 1,151.02 | -15.33 | 154.41 | 338.51 | 328.75 | 923.92 |
Objects of the Issue
| S. No. | Objects Of The Issue | Expected Amount (in Crores) |
|---|---|---|
| 1 | Prepayment or scheduled re-payment, in full or part, of certain outstanding borrowings availed by Company | 320.90 |
| 2 | Investment in our wholly owned Subsidiary, PMHPL (which also operates hospital in Srinagar), for repayment/prepayment of borrowings, in full or part, of PMHPL | 54.10 |
| 3 | General Corporate Purposes | |
| Total | 375.00 |
About Company
Incorporated in1987, Paras Healthcare Limited is a leading clinical specialty-led hospital platform providing tertiary and quaternary healthcare services across North India, Bihar, and Jharkhand under the "Paras Health" brand. The company operates eight hospitals with an aggregate bed capacity of 2,211 beds across Gurugram, Panchkula, Patna, Darbhanga, Kanpur, Udaipur, Ranchi, and Srinagar as of June 30, 2026.
It specializes in cardiac sciences, oncology, neurosciences, gastro sciences, orthopedics & sports injury, and renal sciences (CONGOR specialties), which contributed 75.30% of revenue in Fiscal 2026.
Paras Healthcare has over 20 years of operating history and follows a balanced growth strategy through mature, emerging, and new hospitals. The company plans to expand its network with a 300-bed hospital in Gurugram and a 500-bed hospital in Ludhiana, increasing total capacity to 3,011 beds by March 2028.
As of March 31, 2026, it had 4,670 employees, including 1,084 doctors and 1,937 nurses.
Strengths
- Leading healthcare provider in North India, Bihar, and Jharkhand.
- Network of 8 hospitals with 2,211-bed capacity.
- Strong Paras Health brand with over 20 years of experience.
- Focus on high-acuity CONGOR specialties.
- Balanced portfolio of mature, emerging, and new hospitals.
- Strong occupancy growth and operational efficiency.
- Experienced workforce of 1,011 doctors and 1,665 nurses.
- Expansion pipeline to reach 3,011 beds by FY28.
- Advanced clinical infrastructure and standardized care protocols.
Paras Healthcare IPO Details — Frequently Asked Questions
What is Paras Healthcare IPO?
What is the price band of Paras Healthcare IPO?
What is the lot size and minimum investment for Paras Healthcare IPO?
When will Paras Healthcare IPO open and close for subscription?
What is the issue size of Paras Healthcare IPO?
When is the Paras Healthcare IPO listing date?
Is Paras Healthcare a Mainline IPO or SME IPO?
How can I apply for Paras Healthcare IPO?
Disclaimer
No financial information published within this application, including but not limited to information regarding securities or IPOs, should be considered as advice to buy or sell securities or to invest in IPOs, or as a guide to doing so in any way whatsoever. All content published in this application is provided solely for educational and informational purposes, and under no circumstances should it be used for making investment decisions. We are not a SEBI registered analyst.
Readers must consult a qualified financial advisor before making any actual investment decisions based on information published in this application. The information in this application is based on information available as of the date of publication, along with market perceptions, and may be subject to change without notice.